---
document_datetime: 2024-02-08 11:25:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/omjjara-epar-all-authorised-presentations_en.pdf
document_name: omjjara-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.835317
conversion_datetime: 2025-12-22 07:59:54.311504
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Pack size             |
|------------------|-------------------|------------|---------------------------------------|---------------------------|-----------------------|-----------------------|
| EU/1/23/1782/001 | Omjjara           | 100 mg mg  | Film-coated tablet Film-coated tablet | Oral use Oral use         | bottle (HDPE)         | 30 tablets 30 tablets |
| EU/1/23/1782/002 | Omjjara           | 150        |                                       |                           | bottle (HDPE)         |                       |
| EU/1/23/1782/003 | Omjjara           | 200 mg     | Film-coated tablet                    | Oral use                  | bottle (HDPE)         | 30 tablets            |